Followers | 664 |
Posts | 46918 |
Boards Moderated | 2 |
Alias Born | 03/30/2009 |
Saturday, August 05, 2017 11:15:24 AM
1. Extremely positive results from the trials.
2. A very lucrative buyout offer from a big pharma company.
In the absence of these, the pps will continue to wallow where it currently is or lower. OncoSec will have to prove itself, which it, obviously, has yet to do, to its doubters of which there are many.
$ONCS
Success is never final; failure is never fatal. It's courage that counts.--John Wooden (1910-2010)
Courage is being scared to death, but saddling up anyway.--John Wayne (1907-1979)
Recent ONCSQ News
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/13/2024 07:30:19 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM